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Abstract  Nowadays,  cellular  physiology  is  best  understood  by  analysing  their  interacting
molecular  components.  Proteins  are  the  major  components  of  the  cells.  Different  proteins
are organised  in  the  form  of  functional  clusters,  pathways  or  networks.  These  molecules  are
ordered in  clusters  of  receptor  molecules  of  extracellular  signals,  transducers,  sensors  and
biological  response  effectors.  The  identiﬁcation  of  these  intracellular  signalling  pathways  in
different cellular  types  has  required  a  long  journey  of  experimental  work.
More than  300  intracellular  signalling  pathways  have  been  identiﬁed  in  human  cells.  They
participate  in  cell  homeostasis  processes  for  structural  and  functional  maintenance.  Some  of
them participate  simultaneously  or  in  a  nearly  consecutive  progression  to  generate  a  cellular
phenotypic  change.
In this  review,  an  analysis  is  performed  on  the  main  intracellular  signalling  pathways  that
take part  in  the  cellular  proliferation  process,  and  the  potential  use  of  some  components  of
these pathways  as  target  for  therapeutic  interventionism  are  also  underlined.
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PALABRAS  CLAVE
Vías  de  sen˜alización
intracelulares;
Proceso  de
proliferación  celular
Interacción  de  las  vías  de  sen˜alización  intracelulares  participantes  en  la  proliferación
celular:  potencial  blanco  de  intervencionismo  terapéutico
Resumen  La  ﬁsiología  celular  es  actualmente  mejor  entendida  a  partir  de  sus  componentes
moleculares  interactuantes.  Las  proteínas  son  las  principales  biomoléculas  que  constituyen
las células.  Las  diferentes  proteínas  se  organizan  en  asociaciones  formando  conjuntos,  vías,
o redes  funcionales.  Estos  conjuntos  se  encuentran  organizados  en  moléculas  receptoras  de
sen˜ales extracelulares,  transductoras,  sensoras  y  efectoras  de  respuestas  biológicas.  La  identi-
ﬁcación de  las  diferentes  vías  de  sen˜alización  intracelulares  en  los  diferentes  tipos  de  células
ha requerido  largas  jornadas  de  trabajo  experimental.
Se han  identiﬁcado  más  de  300  vías  de  sen˜alización  intracelular  en  las  células  humanas,
las cuales  participan  en  los  procesos  celulares  básicos  y  especializados  para  mantener  la
homeostasis  estructural  y  funcional.  Varias  de  ellas  participan  de  forma  simultánea  o  cercana-
mente consecutiva  en  la  generación  de  un  cambio  fenotípico  celular.
En esta  revisión  analizamos  las  principales  vías  de  sen˜alización  intracelular  que  participan  en
el proceso  de  proliferación  celular  y  remarcamos  la  estrategia  de  utilizar  algunos  componentes
de estas  vías  como  blanco  de  un  potencial  intervencionismo  terapéutico.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este  es
un artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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he  capacity  of  human  beings  to  see,  perceive  and  respond
o  environmental  signals  depends  on  the  activation  of  intra-
ellular  signalling  pathways  of  their  different  constituting
ells.  These  signalling  pathways  provide  mechanisms  to
rganise  molecular  information  through  cells,  as  it  occurs
ith  the  central  nervous  system  when  it  conducts  the  trans-
uction  of  environmental  information  and  organises  the
omprehensive  response  of  the  different  body  organs.  In  this
ay,  sense  organs  are  sensitive  to  certain  kinds  of  stimuli  (for
xample,  light,  pressure  or  sound  waves),  given  that  cell  sur-
ace  receptors  bind  to  speciﬁc  ligands.  One  cell  may  have
ozens  of  different  receptors  that  simultaneously  receive
ignals  and  transmit  them  to  the  inside  of  the  cell  at  the
ame  time.  All  cells  use  speciﬁc  intracellular  signalling  path-
ays  to  record  incoming  information,  to  translate  it,  to
ake  different  molecules  interact  and  to  produce  a  biologi-
al  response,  thus  generating  a  speciﬁc  phenotypic  pattern.1
Signalling  pathways  mainly  consist  of  a  protein  chain
here  proteins  interact  with  each  other  in  a  previous
equence  that  was  established  through  evolution.  Plants
nd  animals  share  certain  basic  intracellular  signalling
echanisms;  however,  some  organisational  components  are
redominant,  while  others  are  less  frequent  and  certain
athways  are  unique  to  each  kingdom.
Over  the  last  decades,  a  large  number  of  intracellular
ignalling  pathways,  each  with  countless  molecular  compo-
ents,  have  been  identiﬁed.  This  characterisation  has  been
onducted  in  the  context  of  different  cellular  processes
f  speciﬁc  types  of  cells,  in  conditions  of  both  health  and
isease.  A  general  understanding  has  been  reached  in  rela-
ion  to  how  these  groups  of  molecules  work  in  terms  of
ircuits  and  complex  systems.
The  normal  development  and  functioning  of  multicellular
rokaryotes  and  eukaryotes  depend  on  a  consecutive  series
m
c
p
mf  cellular  interactions  based  on  biochemical  changes.  The
ifferent  cellular  stages  are  mainly  due  to  genetic  transcrip-
ion  patterns  that,  upon  translation,  produce  the  interaction
ith  other  molecules  and,  ﬁnally,  regulate  different  cellular
unctions.
Cloning  and  sequencing  of  DNA  segments  and  puriﬁca-
ion  and  sequencing  of  proteins  have  led,  for  example,
o  understand  how  some  oncogenes  code  for  growth  fac-
ors  (such  as  v-Sis)  and  to  recognise  their  receptors  (such
s  ErbB)  and  signalling  pathway  proteins  (such  as  v-Src).
ikewise,  it  has  been  demonstrated  that  the  transduction
f  signals  occurs  through  both  second  messengers,  and
rotein--protein  interactions  and  protein--nucleic  acid  inter-
ctions,  or  how  epigenetic  cellular  conditions  modify  the
ffector  response  due  to  extracellular  signals.2
In  this  article,  the  general  principles  of  intracellular
ignalling  pathway  functioning  will  be  described,  and  the
odular  organisation  of  pathways  participating  in  the  cellu-
ar  proliferation  process  will  be  analysed,  as  an  example  of
 complex  molecular  model  that  cells  use  to  conduct  various
ellular  processes.
roteins as participating biomolecules
roteins  are  the  most  common  and  complex  biomolecules
ithin  cells,  and  they  constitute  their  structural  and
unctional  elements.  Proteins  are  functional  molecules  of
iological  work.  Based  on  their  direct  genetic  coding  in
uman  cells,  there  would  be  22,000  different  proteins;  how-
ver,  this  number  is  increased  more  than  10  times  due
o  the  different  transcription  combinations  of  genes  and
ost-transductional  changes  that  occur  in  the  endoplas-
ic  reticulum  and  Golgi  apparatus.  They  are  essentially
omposed  of  20  types  of  amino  acids  in  different  pro-
ortions.  There  are  small  proteins  (40--80  amino  acids),
edium  and  large  (more  than  10,000  amino  acids),  and
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they  are  biochemically  organised  into  amino  acid  chains  (pri-
mary  structure),  into  helices  and  folded  sheets  (secondary
structure),  into  small  three-dimensional  molecules  formed
by  attraction  and  repulsion  between  amino  acids  (ter-
tiary  structure),  and  into  large  three-dimensional  molecules
formed  by  the  joining  of  smaller  structures  (quaternary
structure).  Several  protein  afﬁnity  and  sequencing  studies
conducted  over  the  last  decades  have  demonstrated  that
speciﬁc  peptide  segments  or  intramolecular  domains  work
in  a  semi-independent  manner  and  are  commonly  identi-
ﬁed  with  speciﬁc  functions,  such  as  kinase  and  phospholipid
binding  domains.  Proteins  are  biomolecules  that  interact
with  other  kinds  of  small  molecules  or  with  adjacent  proteins
and  modify  them  by  producing  new  intramolecular  changes,
which  are  biological  activation  indicators.  Two  main  protein
function  activation  or  repression  mechanisms  are  phospho-
rylation/dephosphorylation  and  GTP  or  GDP-binding.1,3,4
Various  kinds  of  proteins,  due  to  their  wide  range  of
type,  shape,  domain,  response  and  interconnectivity  with
other  proteins,  are  usually  main  components  in  the  recep-
tion,  transduction,  regulation  and  control  of  extracellular
and  intracellular  signals.  The  different  kinds  of  bioactive
proteins  are  essential  for  the  biochemical  response  in  intra-
cellular  signalling  pathways,  which  ultimately  lead  to  a
structural  and  functional  phenotypic  change  in  several  cells.
Each  live  cell  contains  molecular  participation  mechanisms
that  ‘‘turn  on’’  and  ‘‘turn  off’’  the  responses  for  different
electrical  and  chemical  signals.
Cellular signalling systems
Transduction  of  signals,  sensors  and  molecular
effectors
Intracellular  proteins  are  organised  into  groups  by  function,
and  these  groups  are  generally  located  in  speciﬁc  subcellu-
lar  compartments.  The  basic  components  of  an  intracellular
signalling  pathway  comprise  the  following  molecules:  the
extracellular  signal,  signal  receptors,  transducers,  sensors,
effectors  and,  ﬁnally,  the  activation  of  the  cellular  response
to  express  a  speciﬁc  phenotype.1,5 Extracellular  signals
may  be  long-distance  or  short-distance,  are  generally  large
and  hydrophilic  molecules,  and  correspond  to  neurotrans-
mitters,  hormones  (including  local  hormones),  cytokines,
growth  factors,  cell  surface  molecules  and  sensory  stimu-
lation  molecules.  These  signals  are  bound  to  receptors  by
means  of  4  mechanisms:  juxtacrine,  autocrine,  paracrine
and  endocrine.  Extracellular  signals  may  be  free  in  extra-
cellular  ﬂuid  or  embedded  in  the  extracellular  matrix,  and
the  response  is  dependent  on  whether  the  speciﬁc  receptor
is  present  in  the  cell.  Receptor  proteins  detect  the  signal
at  the  cell  membrane  and  transmit  it  to  internal  trans-
ducer  molecules,  which  consist  of  mainly  3  types:  receptors
associated  with  ion  channels  (they  act  in  the  simplest  and
most  direct  manner),  receptors  associated  with  G-proteins
(monomeric  and  heterotrimeric)  and  receptors  associated
with  enzymes  (mostly  with  kinase  activity)  that  help  to
control  complex  cellular  behaviours.3,4 Many  extracellu-
lar  signalling  molecules  interact  with  more  than  one  kind
of  receptor.  Signals  reaching  receptors  associated  with  G-
proteins  or  enzymes  are  transferred  to  complex  transmission
s
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ystems  formed  by  series  of  intracellular  signalling
olecules  and  their  activation  produces  speciﬁc  covalent
nd  conformational  changes  that  turn  them  into  substrates
f  the  following  reaction  within  the  signalling  pathway.
xcept  for  some  small  molecules,  such  as  cyclic  GMP,
yclic  AMP  and  Ca2+,  most  signalling  molecules  are  proteins.
n  general,  small  molecules  considerably  amplify  signals
nd  act  as  a stimulus  for  the  simultaneous  activation  of
everal  surrounding  signalling  pathways.  Activated  proteins
enerally  go  through  one  or  few  pathways,  and  some  of
hem  act  as  a  sequential  part  of  the  pathway,  others  act
s  molecular  hubs  for  one  or  several  pathways,  and  oth-
rs  act  as  scaffolding  molecules.1,6 Transducer  molecules
ass  on  the  signal  to  intracellular  sensor  molecules  and
ffector  molecules;  the  ﬁrst  may  be  intermediaries  or  ﬁnal
lements  of  speciﬁc  signalling  pathways;  some  effector  pro-
eins  (for  example,  transcription  factors)  may  act  on  single
r  multiple  molecular  targets  and  conduct  processes,  such
s  exocytosis,  phagocytosis,  actin  remodelling,  metabolic
athway  activation  and  genetic  expression.  De  novo  pro-
ein  synthesis  is  generally  required  for  the  implementation
f  molecular  interaction  programmes.  The  different  kinds
f  signalling  pathways  used  by  cells  to  regulate  their  dif-
erent  interrelated  cellular  processes  are  interconnected
hrough  hub  molecules,  forming  complex  networks  with  sev-
ral  signalling  pathways.  During  their  activation,  signals
ay  travel  through  some  signalling  pathways  in  particular,
sing  a  preferred  or  canonical  route,  or  eventually  using
n  alternative  or  non-canonical  route.1 The  termination  of
he  activation  of  intracellular  signalling  pathways  implies
topping  the  local  process  in  one  or  several  components
y  means  of  the  action  of  opposing  enzymes  (for  example,
inase  vs.  phosphatase)  or  speciﬁc  inhibitors.  From  an  evolu-
ionary  point  of  view,  the  genome  contains  all  the  structural
odes  for  the  components  of  the  different  signalling  path-
ays.  Thus,  for  example,  in  the  differentiation  process,
ach  specialised  cell  deactivates  the  coding  for  molecules
articipating  in  the  cellular  proliferation  process  and  acti-
ates  the  coding  for  molecules  participating  in  specialised
atabolism  processes  or  specialised  functioning  processes
or  structural  and  functional  phenotype  programmes  imple-
ented  by  terminally  differentiated  cells.
The  activation  of  intracellular  signalling  pathways  is
arefully  organised  in  time  and  space.  The  signalling  pro-
ess  starts  outside  the  cell  and  continues  inside  it,  while
ellular  response  occurs  in  an  inside-out  fashion.  For  each
‘on’’  molecular  activation  mechanism,  there  is  an  ‘‘off’’
eactivation  mechanism.  The  activation  language  of  the
athway  is  established  by  direct  protein--protein  interaction
r  through  its  covalent  modiﬁcations,  such  as  phosphoryla-
ion  and  acetylation,  caused  in  the  pathway  by  the  upstream
iomolecule.  This  activation  requires  the  adequate  tem-
orospatial  coordination  of  its  components.  Some  cellular
esponse  patterns,  such  as  growth  increase  and  cell  divi-
ion,  imply  changes  in  both  genetic  expression  and  synthesis
f  new  proteins  (slow  responses),  while  changes  in  cellu-
ar  movement,  secretion  or  metabolism  do  not  require  the
articipation  of  nuclear  machinery  and  occur  more  rapidly.The  ‘‘on’’  and  ‘‘off’’  functioning  in  intracellular
ignalling  pathways  has  a  high  level  of  cellular  plasticity,  and
hese  signalling  pathways  are  constantly  being  remodelled
y  external  or  internal  signals  required  for  the  maintenance
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f  cellular  homeostasis.  Mechanisms  that  deactivate  signals
re  as  important  as  those  which  activate  them.  Complex
ellular  behaviours  are  usually  controlled  by  networks  of
rotein-kinases;  these  kinases  can  also  modulate  compo-
ents  of  their  own  signalling  pathways,  components  of
ther  surrounding  signalling  pathways  or  of  related  path-
ays  through  hub  molecules.  The  adequate  integration  of
ultiple  intracellular  signalling  pathways  regulates  complex
rocesses,  such  as  development,  proliferation,  differentia-
ion,  response  to  stress,  apoptosis,  etc.  Alterations  in  the
egulation  of  signalling  pathways  lead  to  the  inadequate
ctivation  of  the  cellular  response  and  to  many  diseases.  The
nvestigation  of  intracellular  signalling  pathways  in  different
ypes  of  cells  is  an  active  area  and  there  are  constantly  new
iscoveries.1,6,7
ain intracellular signalling pathways
articipating in various structural
nd  functional cellular processes
he  biomolecular  pathways  of  intracellular  signalling  are
roups  of  proteins  and  other  biomolecules  arranged  in
ascades  of  spatio-temporal  interactions  and  they  are
esponsible  for  cellular  phenotypic  characteristics.  Each
olecular  signalling  pathway  is  generally  located  in  a  sep-
rate  subcellular  compartment.6 Information  on  signalling
athways  or  signalosome  is  essential  for  the  construction
f  models  of  biological  systems.  The  Kyoto  Encyclopaedia  of
enes  and  Genomes  (KEGG)  is  one  of  the  databases  that  con-
ains  the  main  intracellular  signalling  pathways  participating
n  the  regulation  of  the  main  cellular  processes  (Table  1)8;
ome  of  them  use  small  messenger  molecules,  also  known  as
econd  messengers,  for  the  transmission  and  ampliﬁcation
f  messages,  while  others  mainly  use  proteins  as  messengers
nd  internal  sensors.1 The  ﬁrst  group  is  formed,  for  example,
y  the  pathways  of  cyclic  AMP,  cyclic/NAADP  ADP-ribose,
oltage-operated  channels  (VOC),  receptor-operated  chan-
els  (ROC,  such  as  K+,  Ca2+ or  Cl−),  the  activation  pathway
f  phospholipase-C  (PLC)  that  breaks  down  phosphatidyli-
ositols  of  the  cell  membrane,  the  activation  pathway  of
hosphatidylinositol-3-kinase  (PI3K,  which  phosphorylates
IP2  and  forms  PIP3),  the  nitric  oxide/cyclic  GMP  pathway,
he  redox  signalling  pathway,  the  phospholipase-D  (PLD)
athway,  the  sphingomyelin  pathway,  the  AMP  pathway,  the
AD  pathway  and  many  other  pathways  participating  in
he  metabolism.  The  second  group  is  formed  by  mitogen-
ctivated  kinases  (MAPK)  pathways,  the  nuclear  factor  B
NF-B)  pathway,  the  Janus  kinase/signal  transducer  and  acti-
ator  of  transcription  (JAK/STAT)  pathway,  the  SMAD,  WNT,
edgehog,  Hippo,  Notch  pathways,  the  endoplasmic  reticu-
um  stress  pathway  and  several  other  pathways.
ethods that allow for the investigation of
ntracellular signalling pathway components
he  elucidation  of  intracellular  signalling  pathways  has  led
o  the  conduction  of  several  trials  with  protein  genomic
nd  biochemical  techniques  in  dynamic  models  of  normal
nd  tumour  cells.7 The  identiﬁcation  of  a  speciﬁc  path-
ay  takes  years  of  experimental  work.  The  participation
i
c
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nd  importance  of  a  speciﬁc  protein  in  the  signalling  pro-
ess  is  determined  using  different  experimental  strategies
hich  are  frequently  combined,  such  as  the  introduction
r  deactivation  of  a  gene  that  codes  for  said  protein,  the
ssessment  of  its  expression  and  its  post-transductional  acti-
ation/deactivation,  all  of  which  is  related  to  a  speciﬁc
henotypic  cellular  effect.  The  deactivation  of  proteins
articipating  in  intracellular  signalling  pathways  has  been
tudied  using  genetic  molecular  techniques  aimed  at  block-
ng  or  reducing  their  genetic  expression,  such  as  knock-out
nd  knock-down  techniques.9 To  explore  proteins  activated
y  phosphorylation,  speciﬁc  antibodies  are  used  or  proteins
arked  with  radioactive  ATP.  To  identify  interacting  pro-
eins,  co-immunoprecipitation  assays  are  conducted  and,
pon  identiﬁcation  of  interactive  proteins,  their  active
omains  can  be  recognised  using  recombinant  DNA  assays
targeted  mutagenesis)  through  the  creation  of  mutant  pro-
eins,  and  their  interaction  and  importance  can  be  analysed.
 strategy  that  facilitates  the  identiﬁcation  of  proteins  par-
icipating  in  any  speciﬁc  intracellular  signalling  pathway  is
o  conduct  a  populational  study  of  tens  of  thousands  of  fruit
ies  or  nematodes  treated  with  a  mutagen,  and  to  com-
are  these  to  the  control  group,  so  as  to  identify  mutants
ith  an  altered  phenotypic  trait  due  to  the  inappropriate
unctioning  of  one  or  several  signalling  pathways.  In  these
ases,  altered  genes  that  code  for  proteins  participating  in
ignalling  cascades  are  identiﬁed  and  compared  to  their  cor-
esponding  control  groups.1,4 One  of  the  cases  that  requires
he  greatest  amount  of  experimental  work  is  to  determine
he  location  of  a  participating  protein  either  downstream
r  upstream  a  signalling  pathway,  compared  to  the  other
articipating  proteins.
The  cumulative  experimental  study  in  this  area  has  iden-
iﬁed  a  great  number  of  intracellular  molecular  signalling
athways  related  to:  global  cellular  functions,  such  as
etabolism,  proliferation,  apoptosis;  specialised  cellular
unctions,  such  as  immunological  response,  transcription
actor  interactions,  and  protein-protein  interactions;  and
ellular  functions  altered  in  the  presence  of  different
iseases.10 To  analyse  this  large  amount  of  informa-
ion,  it  was  necessary  to  resort  to  bioinformatics  for
he  construction  of  registration  databases  and  molecular
nteractions  (nodes),  such  as  BioPAX,  Pathway  Interaction
atabase,  Reactome,  BioCarta,  KEGG,  GenMAPP,  Genenet-
ork,  Cytoscape,  NetPath,  among  others.  Many  of  these
ere  constructed  with  the  collaboration  of  interdisciplinary
roups,  for  instance  the  NetPath  database,  which  is  a  project
reated  by  both  the  Pandey  Lab  (John  Hopkins  Univer-
ity)  and  the  Institute  of  Bioinformatics  (Bangalore,  India).
ome  mega  databases,  such  as  that  of  the  National  Cen-
re  of  Biotechnology  Information  (NCBI),  Pathguide  and
ikiPathways11,12 form  multiple  databases  of  modules  or
odes  related  to  cellular  signalling  pathways  from  various
ypes  of  normal  cells  and  several  diseased  cells.  The  KEGG,13
ased  on  the  integration  of  genomic,  transcriptomic,
roteomic  and  metabolic  data,  has  organised  the  maps  cor-
esponding  to  more  than  300  human  intracellular  signalling
athways  related  to  metabolism,  the  processing  of  genetic
nformation,  the  processing  of  responses  to  environmental
hanges,  basic  cellular  processes,  different  types  of  differ-
ntiated  cells  from  body  organs  and  systems  and  particular
odels  of  different  human  diseases,8 thus  demonstrating
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Table  1  Number  of  intracellular  signalling  pathways  participating  in  the  main  structural  and  functional  cellular  processes.
Cellular  processes  Number  of  participating
pathways
Examples
Metabolism  130  approx.  Metabolism  of  carbohydrates,  lipids,  amino  acids,
nucleotides,  factors  and  vitamins.  Anabolic
and  catabolic  cycles,  etc.
Genetic /  genomic  processing  22  approx.  Transcription,  translation,  post-translation  changes,
replication  and  reparation  of  the  DNA
Processing  of  extracellular  (environmental)
signals
24  approx.  Reception,  transduction  and  biological  response
Intracellular  transport  of  organelles 4  approx. Endocytosis,  exocytosis;  regulation  of  autophagy
Cell mobility 3  approx. Remodelling  of  the  cytoskeleton,  chemotaxis,  etc.
Cell growth  and  death 14  approx. Cell  cycle,  meiosis,  apoptosis,  pathway  of  p53,  etc.
Intercellular communication  4  approx.  Narrow  junctions,  focal  junctions,  GAP  junctions.
Speciﬁc pathways  of  immunological  system
cells
15  approx.  Signalling  pathways  of  receptors  of  lymphocytes
CD8+ and  CD4+,  etc.
Speciﬁc pathways  of  endocrine  system  cells  12  approx.  Signalling  pathways  of  insulin,  oestrogens,
androgens,  etc.
Speciﬁc pathways  of  circulatory  system  cells  6  approx.  Signalling  pathways  in  the  contraction  of  heart
and blood  vessel  cells
Speciﬁc  pathways  of  digestive  system  cells  10  approx.  Signalling  pathways  participating  in  absorption,
digestion  and  secretion,  etc.
Speciﬁc pathways  of  excretory  system  cells  5  approx.  Signalling  pathways  participating  in  the  regulation
of the  excretion  of  water,  sodium,  bicarbonate,  etc.
Speciﬁc pathways  of  nervous/sensory  system
cells.
14  approx.  Signalling  pathways  of  dopaminergic,  cholinergic
synapses.  Photo-transduction,  olfactory
transduction,  etc.
Speciﬁc pathways  of  cells  participating  in
embryonic  development
4  approx. Signalling  pathways  participating  in  the
development  of  the  dorsoventral  axis,  etc.
Speciﬁc pathways  of  cells  responding  to
environmental  changes
Multiple  Circadian  cycles,  interactions  with  non-pathogenic
organisms
Speciﬁc pathways  of  cells  responding  to Multiple  Antibacterial  responses,  antiviral  responses,  etc.
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that  each  specialised  or  basic  cellular  process  requires  the
participation  of  some  or  multiple  intracellular  signalling
pathways  that  work  in  a  simultaneous  manner.  These  inter-
acting  groups  of  intracellular  signalling  pathways  that  gener-
ate  a  phenotypic  change  are  called  modules.7 Basic  cellular
process  pathway  modules  include  molecular  transport  and
catabolism,  cellular  mortality,  cellular  growth,  death  and
communication  (all  of  which  have  speciﬁc  sub-pathways).
Pathway  modules  identiﬁed  with  diseases  include  those
related  to  some  cancers  (colorectal,  pancreatic),  immuno-
logical  diseases  (asthma,  erythematosus  lupus),  neu-
rodegenerative  diseases  (Alzheimer’s,  amyotrophic  lateral
sclerosis),  addictions  (to  cocaine,  to  morphine),  cardiovas-
cular  diseases  (cardiomyopathic,  hypertrophic),  endocrine
and  metabolic  diseases  (diabetes  mellitus  types  1  and  2),
infectious  diseases  (infection  by  salmonella,  inﬂuenza  A).1,6
These  maps  make  it  possible  to  understand  how  the  over-
activation  or  repression  of  gene  expression  resulting  from
mutations,  epimutations  or  changes  in  the  number  of  copies
in  a  speciﬁc  region  of  the  human  genome  modify  the  acti-
vation  or  repression  of  speciﬁc  intracellular  signalling  and
lead  to  structural  and  functional  changes  in  cells.  In  the
same  way,  the  study  of  these  molecular  maps  facilitates
possible  interventions  to  use  or  design  molecules  with  bio-
chemical  afﬁnity  and  target  altered  molecules,  so  as  to  block
a
t
d
pr  modify  the  speciﬁc  biochemical  reaction,  produce  a  ther-
odynamic  change  in  the  intracellular  signalling  pathway
nd,  ﬁnally,  generate  a change  in  the  genetic  expression
nd  cell  phenotype.  The  correction  of  the  functioning  in
ltered  intracellular  signalling  pathways  may  limit  or  reverse
ellular  and  tissue  damage  and  recover  the  homeostasis.14
s  an  example  of  the  participation  in  several  intracellular
ignalling  pathways  in  some  modules  or  programmes  of  cel-
ular  phenotypic  processes,  the  main  intracellular  signalling
athways  participating  in  the  division  and  proliferation  of
ukaryotes  will  be  brieﬂy  analysed.
odule of intracellular signalling pathways
articipating in cell division and proliferation
ycles
otential  targets  of  molecular  interventions
ukaryotes,  depending  on  the  activation/deactivation,  devi-
tion  or  modulation  in  the  networks  of  signalling  pathways  of
he  cell  division  and  proliferation  cycle,  may  pass  through  4
ifferent  stages:  senescence,  apoptosis,  differentiation  and
roliferation.1,3
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The  module  of  cell  division  and  proliferation  consists  of
 main  groups  of  intracellular  signalling  pathways:  those
or  the  control  of  the  cell  cycle,  those  for  the  activation
f  metabolic-anabolic  pathways,  those  for  activation  or
emodelling  of  the  cytoskeleton,  and  DNA  replication  and
epair.  In  the  cell  proliferation  process,  cells  self-reproduce
y  means  of  intracellular  growth  and  division  in  2  identical
opies,  which  implies  that  the  cell  needs,  at  least,  to
ncrease  its  biomass  and  replicate  its  genome.  Different
rowth  factors  (GF)  activate  cells  during  interphase  so  that
hey  develop  during  their  cell  cycle  and  increase  their  cell
ass  by  increasing  the  biosynthesis  of  macromolecules
hrough  the  activation  of  anabolic  signalling  pathways.  GF
ctivate  the  MAPK/Ras/RAf/ERK  pathway  to  produce  the
ynthesis  of  3  types  of  cyclins  D  (D1,  D2  and  D3)  and  other
ositive  mitosis-regulating  proteins  (Myc  and  Jun);  cyclin  D1
inds  to  CDK4/6  to  form  an  effective  complex  to  activate
everal  substrates  required  to  initiate  the  cell  cycle,  such
s  Myc  and  AP-1.  Cyclin  D  is  regulated  by  the  MAPK/Ras,
-catenin-Tcf/LEF,  PI3K  and  Rho/FAK.  The  availability  of
yclin  D  in  cells  is  controlled  by  a  balance  between  its
as/Raf/MAPK-dependent  synthesis  and  its  Ras/PI3K/AKT,
SK3  and  SCF-dependent  synthesis.1
The  cell  cycle  is  divided  into  2  main  phases:  phase  M  and
nterphase.  Phase  M  includes  the  consecutive  phenomena
f  mitosis  and  cytokinesis.  Interphase  is  divided  into  phases
1,  S  and  G2,  phase  S  being  equivalent  to  the  period  of
NA  synthesis.  In  phase  G1,  the  cell  increases  its  size  and
ctivates  the  replication  of  DNA;  in  phase  G2,  the  cell  con-
inues  to  grow  and  mitosis  is  activated;  in  phase  M,  the
ell  stops  growing  and  is  divided  into  2  daughter  cells  by
eans  of  cytokinesis.  After  cell  division,  or  ‘‘post-mitosis’’
hase,  each  daughter  cell  goes  through  the  interphase  and
s  prepared  for  2  situations:  another  cell  division  or  a non-
roliferation  status.  The  following  paragraphs  summarily
escribe  the  main  molecules  participating  in  the  signalling
athways  of  the  cell  division  and  proliferation/growth  cycle
for  more  details,  refer  to  Berridge,  2012).1,15
Phase  G1  is  called  growth  phase,  during  which  millions
f  proteins,  enzymes,  biolipids  and  nucleotides  are  formed.
hese  are  required  for  the  biosynthesis  of  the  cytoplasm,
ell  membranes,  organelles,  DNA  and  RNA.  The  duration  of
1  varies  greatly  from  one  cell  to  the  other  and  is  under
he  control  of  protein  p53.  Intracellular  signalling  pathways
articipating  through  GF  are  mitogen-activated  protein
inases  (MAPK)  pathways  or  cascades,  the  WNT  pathway
hat  acts  by  means  of  -catenin  and  the  PI3K  pathway.  These
ncrease  transcription  in  cyclin-dependant  cyclin/kinase
CDK)  complexes  and,  in  particular,  in  cyclin  D,  which  acts
n  the  retinoblastoma  protein  to  remove  its  inhibitory  effect
owards  E2F,  which  activates  the  formation  of  cyclins  E  and
,  and  these  cause  cells  to  enter  into  phase  M.  In  contrast
ith  these  positive  effects,  pathways  of  transformation
rowth  factors  (TGF)/Smads  act  by  preventing  the  cell
rom  starting  the  cell  cycle  through  the  expression  of  CDK
nhibitors  (INK4  and  Cip/Kip  families)  and  p53.  In  particular,
53  stops  the  cycle  when  DNA  is  not  correctly  replicated,
hus  producing  proteins  p21,  GADD45  and  14-3-3,  and
romoting  the  transcription  of  apoptotic  factors.15
As  mentioned  before,  after  the  cell  receives  GF,  cyclin  D
s  rapidly  synthesised,  and  this  continues  to  occur  through-
ut  the  cell  division  cycle.  However,  cyclin  E  appears  as
C
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 peak  towards  the  end  of  G1;  cyclin  A  only  appears  in
hases  S  and  G2;  and  cyclin  B  is  expressed  in  phases  G2  and
,  while  CDK  are  constitutively  produced.  In  contrast  with
hese  cyclin  increases,  the  cyclin/CDK  inhibitor  is  reduced
s  from  the  beginning  of  phase  G1,  which  continues  to  occur
hroughout  all  the  phases  of  the  cell  cycle.  Cyclins/CDK
ork  as  serine-threonine  kinases:  cyclin  D/CDK4-6  phospho-
ylates  protein  Rb,  so  the  family  of  transcription  factors  E2F
ctivate  the  transcription  of  the  genes  of  cyclins  E  and  A,
f  phosphatase  cdc25A  that  remodel  the  chromatin.  Then,
yclin  E/CDK2  and  cyclin  A/CDK2  are  activated  to  start
ith  the  DNA  synthesis,  while  the  function  of  cdc25A  allows
or  the  activation  of  cyclin  B/CDK1  to  begin  the  mitotic
pindle  assembly.16
MAPK  pathways  are  generally  the  most  important
ignalling  pathways  that  regulate  cell  proliferation,  and
yclin  D1  is  the  main  sensor  of  extracellular  signals  that
rives  the  progression  phase  of  the  cycle  from  G1  to  S.17
he  complexity  of  these  pathways  and  that  of  the  cyclin  D1
xpression  will  be  brieﬂy  analysed  below.
APK  pathways
hese  pathways  participate  not  only  in  the  regulation  of  cell
roliferation,  but  also  in  the  regulation  of  cell  differentia-
ion  and  death.  The  module  of  MAPK  pathways  contains  from
 to  5  components  or  rows  (horizontal)  of  protein-kinases
Fig.  1):  a  MAP-kinase-kinase-kinase  (MAPKKK)  that,  at  the
ame  time,  consecutively  activates  a  MAP-kinase-kinase
MAPKK)  and  a  MAP-kinase  (MAPK).  This  phosphorylates  ser-
nes  and  threonines  of  proteins  that  lead  to  changes  in  their
unction  and  in  gene  expression.  The  MAP-kinase  group  has
 families  of  interrelated  components  (vertical  distribution)
hat  receive,  transmit  and  respond  to  different  extracellular
ignals:  ERK,  JNK  and  p/38/SAPK;  in  particular,  the  fam-
ly  of  signalling  pathways  regulated  by  extracellular  signals
ERK)  is  divided  into  2  sub-families  (Fig.  1):  small  ERK1  and
RK2,  and  large  ERK5.17 Each  cascade  or  family/sub-family
esponds  to  different  growth  factors,  differentiation  fac-
ors,  stress  extracellular  signals  and  inﬂammatory  cytokines;
hey  contain  different  scaffolding  proteins  and  activate
ifferent  proteins  or  gene  expression  (some  of  which  are
imilar).  This  means  that  MAPK  pathways  jointly  correspond
o  a  system  of  hundreds  of  proteins  (many  of  them  cor-
espond  to  isoforms  produced  by  the  processing  of  MAPK
enetic  expression)  which  regulate  different  cellular  phys-
ological  functions  by  acting  as  transcription  factors  or
ctivating  nuclear/cytoplasmic  enzymes.18,19 The  main  tem-
orospatial  mechanisms  proposed  so  that  MAPK  pathways
egulate  cellular  functions  are  the  following:  (a)  different
uration  and  intensity  of  extracellular  signals;  (b)  differ-
nt  interactions  between  components  of  the  3  families
nd  different  scaffolding  proteins;  (c)  different  interac-
ions  between  the  3  MAPK  families;  (d)  different  subcellular
ompartmentalisation;  and  (e)  intrinsic  complexity  of  the
ertical  distribution  components  of  each  cascade.17yclin  D1
yclin  D1  is  the  sensor  that  integrates  extracellular  signals
ith  molecular  machinery  that,  bound  to  CDK4-6,  activates
Signaling  networks  in  cell  proliferation  171
p38/SAPS
pathways
JNK1/2 pathwaysERK5 pathwaysERK1/2 pathways
RAS A/B-Raf MEKK 1/4
RAC
MEKK 2/3 MEKK 1/4
MEKK 3/6MKK 4/7MEK 5sMEK 1/2
p38/MAPKJNK 1/2/3ERK 5ERK 1/2
Growth
factors;
mitogens
Growth factors;
mitogens and
other signals 
Basic components of the MAPKs
signal transduction 
pathways
Ligands
MAPK pathways families
MAPKKK
MAPKK
MAPK
Biological response Transcription factors
Cytoplasmic targets
ain  c
w
1
C
a
t
a
a
c
r
o
g
p
r
c
s
o
R
t
c
t
t
c
R
s
t
oFigure  1  Schematic  representation  of  the  m
the  progression  of  the  cell  cycle.  Different  transcription
factors,  such  as  AP-1,  SP-1,  E2F,  OCT-1,  are  induced  by
the  activation  of  pathways  ERK1/ERK2  and  ERK5,  or  path-
ways  PI3K/Akt  and  Wnt/-catenin  (or  others,  such  as  NF-B,
JAK/STAT),  thus  promoting  the  expression  of  cyclin  D1  by
binding  to  their  promoter.  Some  groups  of  transcription
factors  organised  in  functional  complexes,  such  as  MuvB,  B-
Myb,  FoxM1,  DREAM,  E2F,  use  different  feedback  circuits  to
interact  at  different  times  with  cyclin  D1  and  lead  to  the
progression  of  the  cell  cycle  in  its  initial  stages  and  in
the  ﬁnal  stages  of  phase  G1.20,21
As  previously  explained,  proliferating  cells  signiﬁcantly
increase  ATP  production  and  the  synthesis  of  biomolecules,
including  lipids,  proteins  and  nucleic  acids,  so  they  re-
programme  their  metabolic  pathways  and,  instead  of  using
catabolic  cycles,  such  as  that  of  mitochondrial  oxida-
tive  phosphorylation,  they  start  to  use  anabolic  cycles,
such  as  the  aerobic  glycolysis  pathway  and  other  anabolic
routes.22,23 Glycolysis  produces  ATP  more  rapidly  due  to  the
overexpression  of  several  enzymes  used  in  this  pathway  and
provides  a  greater  number  of  intermediary  molecules  for  the
biosynthesis  of  macromolecules.  The  regulating  axis  of
the  cell  cycle  CDK4/pRb/E2F1  is  also  an  important  factor
in  the  control  of  the  energetic  status  and  the  biosynthetic
anabolic  process.23
Upon  activating  the  pathway  PI3K/Akt,  the  cell  increases
the  use  of  nutrients,  particularly  glucose  and  glutamine,
and  the  use  of  carbons  is  re-directed  by  glycolytic
enzymes,  such  as  pyruvate  kinase,  towards  the  synthesis
of  macromolecules.  During  this  phase,  GF  are  bound  to
tyrosine-kinase  receptors  and  other  receptors  associated
o
t
t
momponents  of  the  4  MAPK  pathway  cascades.
ith  proteins  G,  which  stimulate  the  formation  of  inositol
,4,5-trisphosphate  (IP3) and  diacylglycerol,  which  release
a2+ and  turn  on  biosynthesis  pathways.  The  mTOR  kinase,
 serine/threonine  kinase  inhibited  by  rapamycin,  and  the
ranscription  factor  Myc  through  the  pathway  PKB/TSC1/2
re  the  molecules  that  coordinate  the  synthesis  of  proteins
nd  nucleic  acids,  respectively.  Signalling  pathways  of  cell
ycle  progression  and  metabolic  pathways  have  a  two-way
elation,  since  they  both  execute  feedback  controls  between
ne  another.24
Apart  from  these  2  groups  of  signalling  pathways,  another
roup  of  signalling  pathways  participates  in  cell  cycle
rogression:  those  related  to  intracellular  cytoskeleton
emodelling,  which  lead  to  changes  in  the  shape  of  the  cell,
hromosome  alignment,  organelle  movement,  and  polari-
ation  and  separation  of  the  2  daughter  cells  at  the  end
f  mitosis;  in  these,  Rho-GTPase  proteins  work  as  hubs.
ho  proteins,  members  of  the  Ras  superfamily,  regulate
he  assembly  and  organisation  of  cytoskeleton  formations
omposed  of  actin  and  microtubules,  which  contribute  to
he  formation  of  the  mitotic  spindle  and  its  binding
o  the  kinetochore,  coordinate  the  contractile  ring  and
ell  separation  during  cytokinesis,  etc.  Rho  proteins  include
hoA,  Rac1  and  Cdc42,  and  are  interconnected  with  the
ignalling  pathways  MAPK,  Wnt/-catenin  and  PI3K;  in  par-
icular,  they  participate  in  the  JNK  and  p38/SAPK  cascades
f  MAPK  pathways,  in  which  Ras  interact  directly  with  each
f  the  3  proteins,18 transmitting  the  signal  downstream
hrough  the  rows  of  protein-kinases,  activating  cytoskele-
on  remodelling  proteins,  such  as  ROCK,  MKLP1,  PKN  and
Dia.25,26
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Module of intercellular signaling pathways participating in cell proliferation    
Submodule of cell cycle control
pathways
MAPKs/ERK, Wnt, PI3K/Akt;
E2F/DP1/Rb/D-Cdk4-6
Submodule of activation of anabolic
metabolic pathways
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Submodule of activation of anabolic
metabolic pathways
PI3K/Akt/mTOR, HIF1;
Myc/PK M1-2
Submodule of DNA replication
and repair pathways
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iigure  2  Schematic  representation  of  simultaneous  or  nearly
pating in  cell  proliferation.
In  phase  S,  the  genome,  chromosomes  and  histones  con-
inue  to  replicate,  thus  achieving  full  duplication.  The  cyclin
/CDK2  complex  contributes  to  cell  cycle  progression  by
hosphorylating  Rb,  removing  p21,  p27  and  p57,  and  start-
ng  DNA  synthesis.  Cyclin/CDK  complexes  recruit  and  reﬁne
he  molecular  machinery  of  DNA  replication  and  repair.  DNA
ynthesis  goes  through  2  large  signalling  pathways:  synthesis
tself  and  repair  of  previous  DNA  damage  caused  by  exoge-
ous  or  endogenous  agents  (for  example,  oxygen  reactive
ompounds)27 or  the  correction  of  errors  that  occur  during
he  replication  process  (pathways  for  the  repair  of  non-
omplementary  base  pairing).  DNA  damage  response  (DDR)
athways  are  divided  into  pathways  that  repair  the  damage
f  one  chain  (nucleotide  and  base  excision  repair)  or  path-
ays  that  repair  the  damage  of  the  2  chains  (homologous
ecombination  and  pairing  of  non-homologous  terminal  seg-
ents),  using  molecules  that  recognise  the  damage,  such  as
u70/80,  RAD50,  PARP,  FANC,  BRCA;  transducer  molecules,
uch  as  ATM  and  ATR;  and  effector  molecules,  such  as  CHK1
nd  CH2.28,29 P53  works  as  one  of  the  main  coordinating
olecules  between  cell  cycle  pathways  and  DNA  synthesis
athways.
In  phase  G2,  the  cell  continues  with  the  biosynthetic
etabolic  phase,  veriﬁes  the  ﬁdelity  of  the  replicated  DNA
nd  completes  the  formation  of  the  mitotic  spindle.  The
yclin  B/CDK1  complex  controls  the  2  ﬁnal  phases  of  the
ell  cycle.
In  phase  M,  the  nucleus  is  ruptured  and  divided  during  the
ub-phases  prophase,  metaphase,  anaphase,  telophase,  and
he  process  is  completed  during  the  cytokinesis.  In  phase
,  the  nucleus,  cytoplasm,  organelles  and  cell  membrane
re  divided  into  2  cells  that  contain  identical  amounts.
he  main  events  of  this  phase  are  rupture  of  the  nuclear
nvelope,  assembly  of  the  mitotic  spindle,  separation  of
i
p
t
hecutive  interactions  of  intracellular  signalling  pathways  partic-
hromosomes  and  cytokinesis.  Cyclin  B/CDK1  leads  to  the
ormation  of  the  mitotic  spindle,  which  organises  the  poly-
erisation  of  microtubule  networks  to  form  the  organising
entre  (microtubule-organising  centre,  MTOC)  and  regulate
ts  orientation;  in  this  case,  the  mitotic  spindle  assembly
ignalling  pathway  participates  in  the  anaphase  activation
omplex  (anaphase-promoting  complex,  APC).1,5 Chromo-
ome  separation  is  regulated  by  the  APC/Plk1/SCF  complex
hich  hydrolyses  cohesin  molecules.  During  cytokinesis,  the
gcRacGAP/RhoA  complex  restructures  cytoskeletal  ﬁla-
ents  to  form  an  actinomyosin  contractile  ring.26
According  to  the  above  description,  the  phenotypic  mod-
le  used  for  cell  progression  during  the  cell  division  cycle
nd  cell  proliferation  requires  the  participation  of  4  submod-
les  of  intracellular  signalling  pathways  in  a  simultaneous
r  nearly  consecutive  manner,  as  shown  in  Fig.  2.  Each
athway  may  contain  more  than  200  components  organised
n  horizontal  rows  (upstream  and  downstream  arrange-
ents)  and  vertical  rows  (different  cascades  or  families),
s  it  occurs  with  MAPK  pathways  in  particular.  Further-
ore,  each  signalling  pathway  submodule  is  interconnected,
ither  directly  or  indirectly,  with  other  pathway  submod-
les  related,  either  directly  or  indirectly,  to  the  phenotypic
ffect  of  cell  proliferation.
The  analysis  of  this  module  leads  to  the  conclu-
ion  that  the  generation  of  cellular  phenotypic  traits  or
haracteristics  probably  involves  some  or  multiple  pre-
ominant  intracellular  signalling  pathways  and  multiple
ubpredominant  signalling  pathways  that  are  coordinated
n  a  simultaneous  or  nearly  consecutive  manner.  These
nvolve  a  large  number  of  molecular  components  that  may
otentially  be  subject  to  targeted  therapeutic  interven-
ions;  these  molecular  targets  may  mainly  correspond  to
ubs  of  signalling  cascades  of  only  one  pathway  or  to  hubs
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regulating  the  interconnection  with  other  essential  path-
ways  to  achieve  a  speciﬁc  cellular  phenotypic  change.
In  this  way,  in  cell  proliferation,  different  groups  of
researchers  began  a  large  number  of  preclinical  and  clini-
cal,  experimental,  phase  I--II  trials  to  try  to  modify  cell  cycle
reprogramming  in  cancer  cells  through  the  pharmacological
administration  of  active  agents  aimed  at  altering  hubs  of
their  predominant  and  subpredominant  signalling  pathways.
One  of  these  strategies  involved  the  use  of  some  ﬂavonoids
and  purine-derived  compounds  that  regulate  different  CDK
through  their  inhibitory  effect  on  serine-threonine  kinase
domains  and,  thus,  their  high  proliferation  rate.30
The  identiﬁcation  of  alterations  in  the  regulation  of  MAPK
signalling  pathways  is  an  essential  biomarker  in  the  onco-
genesis  of  different  tumours.  For  instance,  in  the  case  of
thyroid  papillary  carcinoma,  3  parts  of  MAPK  pathways,  the
receptor  and  the  transducer  molecules  Ras  and  BRAF,  are
involved  in  more  than  70%  of  the  cases,  and  their  differ-
ential  association  with  the  clinical  behaviour  of  the  disease
has  been  observed  in  some  patients.  In  patients  with  thyroid
papillary  carcinoma  where  conventional  treatment  is  inef-
fective,  the  use  of  tyrosine-kinase  receptor  inhibitors  is  a
therapeutic  alternative.31 The  determination  of  alterations
in  the  components  of  this  pathway  through  the  identiﬁca-
tion  of  structural  mutations  and  changes  in  the  expression
patterns  of  this  receptor  or  RAS/BRAF  in  tumour  cells  are
potential  therapeutic  targets.32,33
Conclusions
The  identiﬁcation  of  intracellular  signalling  pathways  partic-
ipating  in  the  generation  of  different  basic  and  specialised
processes  that  occur  within  cells  allows  for  the  understand-
ing  of  underlying  molecular  mechanisms  of  cell  physiology.
The  elucidation  of  intracellular  signalling  pathways  takes
years  of  experimental  work.
For  the  generation  of  different  cellular  phenotypic
changes,  cells  frequently  use  some  or  multiple  simultaneous
or  nearly  consecutive  intracellular  signalling  pathways,  as
observed  in  the  cell  proliferation  process.  The  identiﬁca-
tion  of  the  main  molecules  that  regulate  signalling  pathways
in  pathological  cellular  processes  makes  it  possible  to  try
to  modify  and  reverse  or  limit  the  alterations  in  basic  and
specialised  cellular  processes  and,  therefore,  alterations  in
tissues  or  organs.  A  more  rational  era  of  molecular  therapy
has  begun.
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